If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Khavinson cardiovascular short-peptide bioregulator
Overview
Cardiogen (Ala-Glu-Asp-Arg / AEDR) is a synthetic tetrapeptide bioregulator developed by Professor Vladimir Khavinson's team at the St. Petersburg Institute of Bioregulation and Gerontology, part of the Khavinson short-peptide family targeting cardiac tissue. Its proposed mechanism involves modulating fibroblast proliferation, suppressing cardiomyocyte apoptosis via p53 downregulation, and upregulating cytoskeletal/nuclear matrix protein expression; a separate in vitro study from the same research group also found that AEDR specifically binds wheat histones (H1, H2B, H3, H4) and their deoxyribooligonucleotide complexes (confirmed via fluorescence quenching). All published research to date is limited to in vitro cell culture and animal models (mice/rats); no human clinical trial data exist, and pricing/dosing protocols circulating among vendors are community-derived and have not been formally validated. Vialdyne releases Cardiogen as a lyophilized tetrapeptide (linear) against a ≥99.0% HPLC main-peak specification, with a batch-specific Certificate of Analysis covering RP-HPLC purity and mass-spec identity; water content, residual solvents and endotoxin are available on request and listed on the COA when tested. Sequence / identity confirmation is documented on the released lot.
Applications & buyer fit
Buyers for longevity-class peptides span research labs working on telomere, collagen, and circadian-rhythm models, plus cosmetic-formulation OEMs incorporating peptides like GHK-Cu into anti-aging finished products. Copper peptides in particular require attention to chelator-free water and EDTA-free buffers in downstream formulation work, incompatibility there is the most common cause of "the peptide didn't work" support tickets in this class.
Sourced for
Buyer fit
Documentation that ships
Procurement note: Copper peptides require chelator-free water and EDTA-free buffers in downstream formulation work.
Primary buyer fit: academic and contract research laboratories.
Specifications
Batch COAs and test reports
Each picture is a low-resolution preview of a report's first page, with batch and report numbers covered. For the full, clear report, ask our sales team, naming the product and strength.
Batch COACardiogen 20 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Independent test fails? Full refund. How it works
Browse all COAs and reportsRegulatory note
Research-use-only reference material; not for human or veterinary use.
Selected literature
Frequently asked questions
The released batch paperwork should state the explicit Ala-Glu-Asp-Arg sequence of the material shipped, not the product name alone. Require the analytical method used to confirm identity, a purity figure tied to that method, and the assay basis, salt form, and water content so preparation calculations are anchored correctly. Without an explicit released-sequence statement, the lot should not enter a qualified workflow.
Since the two are marketed as complementary but target different tissues, myocardium versus endothelium, they must be handled as distinct SKUs with no shared labeling. Give each its own lot record, retained sample, and reconstitution instruction sheet, and keep vials physically separated to prevent mix-ups during combined-protocol work. The Vesugen line carries a defined KED sequence and known mass; the Cardiogen line requires its released sequence confirmed per lot. Label each container with compound name, lot, assay basis, and re-test date, and never rely on visual appearance alone to tell reconstituted solutions apart.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.
Related peptides
9-mer
Khavinson vascular tripeptide (Lys-Glu-Asp, KED)
9-mer
Khavinson neuroprotective tripeptide (Glu-Asp-Arg, EDR)
12-mer
Pineal tetrapeptide · telomere research
Nasal spray listed